U.S. adult smoking rate hits all-time low
Adult cigarette smoking in the U.S. dropped to an all-time low last year, according to new data from the U.S. Centers for Disease Control and Prevention. Based on health surveys from over 27,000 people, only 11 percent of adults reported smoking in 2022, a decrease from 12.5 percent in 2021, reports The Associated Press.
Cigarette smoking has been on the decline since the 1960s, when 42 percent of adults were active smokers, AP notes. Over time, the habit became less socially acceptable as rules like indoor smoking bans meanwhile drove down usage. Smoking has also been proven to cause a number of health problems, including heart disease, lung cancer, COPD, emphysema, asthma, and even death.
But the decline isn't all good — while traditional smoking is on its way out, electronic cigarette usage is actually on the rise, with 6 percent of adults claiming to have participated in the habit in 2022; that's compared to 4.5 percent of adults in 2021. The trend is more concerning for teens, 14 percent of which reported e-cigarette usage in 2022, per other CDC data.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
E-cigarette usage can have dire health consequences, as well. The devices themselves often contain dangerous chemicals like formaldehyde, which can damage the heart and lungs and lead to similar problems as those caused by traditional cigarettes, according to the American Lung Association.
"I think that smoking will continue to ebb downwards, but whether the prevalence of nicotine addiction will drop, given the rise of electronic products, is not clear," Dr. Jonathan Samet, dean of the Colorado School of Public Health, told AP.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Create an account with the same email registered to your subscription to unlock access.
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Chicken with Steph's spice
The Week Recommends This Caribbean-inspired recipe is mouthwateringly delicious
By The Week UK Published
-
A peaceful seaside village in Turkey
The Week Recommends Çıralı has been spared the 'scourge' of all-inclusive resort development
By The Week UK Published
-
Tax plans spell trouble in the North Sea
Talking Point Labour’s tax plans are whipping up a storm. Are the worries of opponents justified?
By The Week UK Published
-
Mold, bugs at listeria-linked Boar's Head meat plant
Speed Read Food safety inspectors reported many violations at a Virginia plant that has been linked to a nationwide deli meat recall
By Peter Weber, The Week US Published
-
Baby food is not as healthy as it should be
Under the Radar Labels are leaving things out. And brands are highlighting only what they want to.
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Why gonorrhoea is becoming 'untreatable'
In the Spotlight Infections hit record high as experts warn about rise in antibiotic-resistant cases
By Elizabeth Carr-Ellis, The Week UK Published
-
Where does MDMA-assisted therapy go from here?
Today's Big Question Psychedelic treatments face a challenge from the FDA
By Joel Mathis, The Week US Published
-
Can dementia be defeated?
Today's Big Question A new report identifies 14 risk factors
By Joel Mathis, The Week US Published